Document is current
Any future updates will be listed below
-
Authors
Kuurdor, Elijah Deku-Mwin
Negoro, Manami
Amexo, Jennifer Xolali
Sugata, Ken
Tonto, Prince Baffour
Simbeya, Anthony
Ohtsuka, Junpei
Yamamoto, Soh
Ogasawara, Noriko
Fukumura, Masayuki
Nosaka, Tetsuya
Kamiya, Hajime
Taniguchi, Kiyosu
- License Information
-
More Information
Article History
Received: 12 November 2025
Accepted: 11 March 2026
First Online: 17 March 2026
Declarations
:
: The study protocol was approved by the Institutional Review Board (IRB) of Mie National Hospital (Approval No: 2023.35). Informed consent was obtained from parents or legal guardians prior to sample collection.
: Not applicable.
: J.O., N.O., M.F., and T.N. hold shares of stock in BioComo, Inc. E.D.K., M.N., A.S., J.O., S.Y., N.O., M.F., T.N., and K.T. are patent applicants for RSV preF ELISA. The other authors declare no competing interests. None of the funders influenced the study’s design, data collection, analysis, publication decision, or manuscript preparation.
